Artwork for podcast Pathfinders in Biopharma
Will the Biotech Rebound Run into Pricing Policy Obstacles?
Episode 20 • 27th February 2024 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:13:25

Share Episode

Shownotes

Drug pricing is already an issue in the U.S. election campaign. Brian Abrahams, MD and Head of Biotech Research at RBC Capital Markets joins the Pathfinders in Biopharma podcast to consider how this, together with other policy developments in the U.S. and worldwide, might affect a resurgent biotech sector.

Follow

Links

Chapters

Video

More from YouTube